RT Journal Article
SR Electronic
T1 Phase Ib study of anti-CSF-1R antibody emactuzumab in combination with CD40 agonist selicrelumab in advanced solid tumor patients
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP e001153
DO 10.1136/jitc-2020-001153
VO 8
IS 2
A1 Machiels, Jean-Pascal
A1 Gomez-Roca, Carlos
A1 Michot, Jean-Marie
A1 Zamarin, Dmitriy
A1 Mitchell, Tara
A1 Catala, Gaetan
A1 Eberst, Lauriane
A1 Jacob, Wolfgang
A1 Jegg, Anna-Maria
A1 Cannarile, Michael A
A1 Watson, Carl
A1 Babitzki, Galina
A1 Korski, Konstanty
A1 Klaman, Irina
A1 Teixeira, Priscila
A1 Hoves, Sabine
A1 Ries, Carola
A1 Meneses-Lorente, Georgina
A1 Michielin, Francesca
A1 Christen, Randolph
A1 Rüttinger, Dominik
A1 Weisser, Martin
A1 Delord, Jean-Pierre
A1 Cassier, Philippe
YR 2020
UL http://jitc.bmj.com/content/8/2/e001153.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.